Subscribe to Search results

Haemophilia directors attended a meeting along with officials and haemophilia centre directors from across Scotland in order to establish "whether there was a general policy on what patients were told and whether there [was] an assessment of risk and if patients were given a choice."

Published on:

At the meeting of Haemophilia directors, officials and haemophilia centre directors from across Scotland a comment was recorded as being made by Dr Henry Watson of Aberdeen Haemophilia Centre that the clinician "would have to make the decision of whether to hand the patient a host of information or outline the benefits/risks of particular products."

Published on:

At the meeting of Haemophilia directors, officials and haemophilia centre directors from across Scotland a comment was recorded as being made by Professor Ludlam that DDAVP could have been used from 1979 but that this was a matter of clinical judgement and "patients were desperate at that time to be prescribed concentrate as this allowed them to treat themselves at home."

Published on:

At the meeting of Haemophilia directors, officials and haemophilia centre directors from across Scotland, Professor Ludlam sought advice on whether haemophilia directors should be looking back to try and identify what had happened to people whose whereabouts and status were unknown. Lynda Towers referred to the Central Legal Office and said that haemophilia directors should follow their advice on whether any further investigation or tracking down of patients was necessary.

Published on:

The Scottish National Blood Transfusion Service sent to the Scottish Executive a paper in response to requests for information from Christine Dora.

Published on:

Thea Teale sent an email to Christine Dora expressing concern about what might come out of the papers which Professor Cash had provided and that they "look carefully for any suggestions that the state of knowledge was other than that which the SNBTS have offered."

Published on:

Christine Dora sent an email to Dr Keel and Lynda Towers stating that she did not understand half of the papers obtained from Professor Cash and asked for advice in relation to the sequence of events regarding testing as might relate to their investigation.

Published on:

Thea Teale wrote to Christine Dora on 30 March, in response to her query about testing, that it was "a balance between sticking to what we were asked to do & anticipating further demands. I am still inclined not to cover testing in the body of the report."

Published on:

Christine Dora circulated a draft of the report 'Hepatitis C and heat treatment of blood products for haemophiliacs in the mid 1980s' to officials.

Published on:

Dr Keel provided comments for Christine Dora in response to the draft report, recommending that the conclusion should be made "more definite". She reminded Christine Dora that the Department of Health was very nervous about financial help.

Published on:

An email chain between Christine Dora and officials in which it is suggested that the investigation report should not provide support for the Haemophilia Society's calls for compensation for those infected with Hepatitis C.

Published on:

John Aldridge wrote in an email to Christine Dora that the Minister should be pointed in the direction of not agreeing to compensation or special priority treatment for those infected with Hepatitis C who may have been infected by NHS treatment.

Published on:

Christine Dora replied to John Aldridge stating that she hoped the ministers would not decide on compensation for those infected with Hepatitis C.

Published on:

Susan Deacon wrote to Lord Philip Hunt regarding her understanding that the Department of Health was considering proposals by the National Blood Authority to settle claims brought under the Consumer Protection Act litigation by 113
people infected through transfusion and expressed concern that any decision in England was bound to result in pressure to settle in similar terms in Scotland and asked if a common approach could be developed.

Published on:

Christine Dora invited the Minister for Health and Community Care to further consider the issue of possible provision of financial help to haemophiliacs infected through blood products.

Published on:

Christine Dora produced her draft report, Hepatitis C and heat treatment of blood products for haemophiliacs in the mid 1980s.

Published on:

The draft HCV/Haemophilia Report was provided to SNBTS and to haemophilia clinicians to enable them to comment and comments were received from them.

Published on:

Christine Dora wrote to Kate Cunningham stating that she would prefer for the Haemophilia Society to have advance sight of the final report on Hepatitis C and heat treatment of blood products for haemophiliacs in the mid 1980s by a few days.

Published on:

Margaret Smith MSP wrote to Susan Deacon asking on behalf of the Health and Community Care Committee that the inquiry extend their remit to include non-haemophiliacs who contracted Hepatitis C through contaminated blood products.

Published on:

Susan Deacon rejected the request to widen the scope of the inquiry.

Published on: